26 results
8-K
EX-3.1
NBRVF
Nabriva Therapeutics plc
16 Sep 22
Material Modifications to Rights of Security Holders
6:02am
and currency hedging and swap agreements, forward rate agreements, interest and currency futures or options and other forms of financial instruments
424B3
o2xseen916ezlrug
1 Nov 21
Prospectus supplement
4:10pm
S-1
rqst1
8 Oct 21
IPO registration
4:14pm
8-K
EX-10.1
1zkbxhv2r pa0ockbq
27 Sep 21
Entry into a Material Definitive Agreement
8:57am
8-K
s3vqh5
27 Sep 21
Entry into a Material Definitive Agreement
8:57am
8-K
EX-10.1
z8d9vft
1 Mar 21
Nabriva Therapeutics Announces $25.4 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:28pm
8-K
EX-10.1
8jw7owgw
14 Dec 20
Nabriva Therapeutics Announces Proposed Public Offering
4:25pm
8-K
EX-3.1
9xihdoqbec3ygtba
3 Dec 20
Material Modifications to Rights of Security Holders
6:04am
8-K
EX-10.1
s247lcgyyz 62ylp9t
1 Jun 20
Nabriva Therapeutics Announces $38 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
6:28am
8-K
EX-10.1
pqar0mp8yfbga1mdxx
20 Dec 19
Nabriva Therapeutics Announces $20 Million Registered Direct Offering
9:07am